GENE ONLINE|News &
Opinion
Blog

Immunology
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Insider: Groundbreaking Malaria Vaccine Reinvigorates the Fight against Disease
2022-03-30
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
CSL Funds Four Australian Research Programs with Research Acceleration Initiative partnership
2021-05-04
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top